Arca Biopharma Stock Predictions

Healthcare > Biotechnology

Buy ABIO

*Your capital is at risk

$2.40

+0 (+0%)

At Close: Nov 29, 2024

Currently predicting for Fri, 5 Jun 2026

ABIO Prediction Chart

ABIO Predictions History

Latest community submissions for ABIO.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
GoldenNugget Pro	May 7, 2019	$10.73 -14.69%	$12.58	X	85.31%	0
NameNotImportant Pro	May 3, 2019	$10.14 -6.97%	$10.90	X	93.03%	0
GoldenNugget Pro	May 3, 2019	$10.52 -3.51%	$10.90	X	96.49%	0
JS Pro	Oct 3, 2018	$0.661 -4.18%	$0.690	V	95.80%	0
JS Pro	Aug 2, 2018	$0.668 -10.19%	$0.740	V	90.30%	0
JS Pro	May 22, 2018	$0.666 +8.17%	$0.620	V	92.60%	0
JS Pro	Nov 17, 2017	$1.37 -5.52%	$1.45	X	94.50%	0
Stockdum Senior	May 17, 2016	$3.37 +0.90%	$3.34	X	99.10%	2

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABIO with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ARCA BIOPHARMA

ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	4.43%	Jun 01
N NVRI $19.53	0.87%	May 20
RUN $12.83	15.51%	May 06
GLBE $31.61	4.05%	May 05
SAP $172.39	8.56%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by